Skip to main content
. 2021 May 28;11:11311. doi: 10.1038/s41598-021-90859-3

Table 1.

Clinical and postmortem characteristic of the analytic cohort.

Measure Mean (SD) or number (%)
Clinical measures at last visit
Age at death (years) 89. 3 (6.51)
Females (%) 811 (68.0%)
Education (years) 16.2 (3.59)
Purdue pegboard test (no. of pegs/30 s) 6.7 (3.37)
Finger-tapping test (taps/10 s) 47.2 (14.57)
Time to cover a distance of 8 feet (seconds) 6.0 (4.23)
Number of steps required to cover 8 feet (steps) 9.0 (3.42)
360 degree turn time (seconds) 7.9 (6.33)
Number of steps to complete a 360° turn (steps) 12.4 (5.69)
Leg stand (seconds) 2.18 (2.77)
Toe stand (seconds) 3.03 (3.54)
Grip strength (kilograms) 32.4 (18.17)
Pinch strength (kilograms) 8.14 (5.00)
Global motor measure 0.67 (0.26)
Global parkinsonism score 17.3 (11.58)
Instrumental activities of daily living disability 1076 (90.3%)
Activity of daily living disability 757 (63.5)
Mobility disability 1038 (87.1)
Postmortem Indices
Postmortem interval (hours) 8.4 (6.04)
Nigral neuronal loss (moderate-severe) 155 (13%)
Lewy bodies (any) 316 (27%)
Pathologic Alzheimer's disease (NIA Reagan) 766 (64%)
TDP-43 (present beyond amygdala) 380 (32%)
Hippocampal Sclerosis (present) 113 (9%)
Macroinfarcts present 430 (36%)
Microinfarcts present 337 (28%)
Atherosclerosis (moderate-severe) 405(34%)
Arteriolosclerosis (moderate-severe) 397 (33%)
Cerebral amyloid angiopathy (moderate-severe) 422 (35%)